Atrium Therapeutics Inc (RNA)
Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 382,517 | 219,868 | 185,082 | 340,396 | 320,448 |
| Marketable Securities | 1,314,352 | 1,281,629 | 410,269 | 270,331 | 85,095 |
| Other current assets | 101,598 | 40,793 | 15,956 | 12,215 | 5,598 |
| TOTAL | $1,798,467 | $1,542,290 | $611,307 | $622,942 | $411,141 |
| Non-Current Assets | |||||
| PPE Net | 23,333 | 12,670 | 8,381 | 6,254 | 4,805 |
| TOTAL | $23,333 | $12,670 | $8,381 | $6,254 | $4,805 |
| Total Assets | $1,958,050 | $1,563,895 | $628,555 | $638,800 | $427,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $195,446 | $98,018 | $80,680 | $51,908 | $29,658 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $269,450 | $138,936 | $127,791 | $60,725 | $46,150 |
| Shareholders' Equity | |||||
| Retained earnings | -1,577,697 | -893,066 | -570,764 | -358,544 | -184,549 |
| Other shareholders' equity | 3,266,297 | 2,318,025 | 1,071,528 | 936,619 | 565,979 |
| TOTAL | $1,688,600 | $1,424,959 | $500,764 | $578,075 | $381,430 |
| Total Liabilities And Equity | $1,958,050 | $1,563,895 | $628,555 | $638,800 | $427,580 |